Showing results (61-70 of 494) with videos related to
Sort By:
Pageof 50
Annals of Internal Medicine|April 17, 2008
The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patientsAaron S Kesselheim, Niteesh K ChoudhryDrug Safety|June 25, 2015
Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and EffectivenessAaron S Kesselheim, Joshua J GagneAnnals of Internal Medicine|April 11, 2018
U.S. Food and Drug Administration Precertification Pilot Program for Digital Health Software: Weighing the Benefits and RisksTheodore T Lee, Aaron S KesselheimAnnals of Surgery|December 25, 2008
Professional oversight of physician expert witnesses: an analysis of complaints to the Professional Conduct Committee of the American Association of Neurological Surgeons, 1992-2006Aaron S Kesselheim, David M StuddertHealth Affairs (Project Hope)|February 10, 2016
Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size CompaniesThomas J Hwang, Aaron S KesselheimOpen Forum Infectious Diseases|February 5, 2020
Incentivizing Antibiotic Development: Why Isn't the Generating Antibiotic Incentives Now (GAIN) Act Working?Jonathan J Darrow, Aaron S KesselheimBMJ Open|October 12, 2019
Application of orphan drug designation to cancer treatments (2008-2017): a comprehensive and comparative analysis of the USA and EUKerstin Noëlle Vokinger, Aaron S KesselheimHealth Policy (Amsterdam, Netherlands)|June 24, 2019
Characteristics of trials and regulatory pathways leading to US approval of innovative vs. non-innovative oncology drugsKerstin Noëlle Vokinger, Aaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 8, 2023
The $5 Billion Hop: Glatiramer Acetate and the US Patent SystemNeeraj G Patel, Aaron S KesselheimJournal of Managed Care & Specialty Pharmacy|August 31, 2021
International reference pricing for prescription drugs: a landscape analysisLeah Z Rand, Aaron S KesselheimPageof 50